-
Foresight hits £130m in waste investment
28 January 2015Infrastructure investment firm Foresight Group said it has invested a total of £130 million ($197 million) in waste-processing projects.
-
Foresight Group invests £4.5m in energy efficiency upgrades at manufacturer
07 August 2014Infrastructure and private equity asset manager Foresight Group has agreed to invest an additional £4.5 million ($7.6 million) in an energy efficiency partnership with construction firm Cemex UK.
-
Foresight agrees £100m solar loan facility
19 May 2014Foresight Solar Fund has agreed a £100 million ($168.2 million) debt facility to help fund its plans to double its operating capacity over the next 12 months.
-
GIB commits £7.5m to £15m London biogas plant
13 May 2014The UK's Green Investment Bank (GIB) is investing £7.5 million ($12.6 million) in an anaerobic digestion plant just outside London.
-
Foresight Solar eyes debt facility and aims to double capacity
07 April 2014Foresight Solar Fund is negotiating loan facilities of up to £100 million ($166 million) to finance further acquisitions.
-
SunEdison agrees financing and imminent sale of first UK projects
03 March 2014SunEdison's first UK solar energy projects are due to be operational later this month, the US-based photovoltaics specialist said.
-
UK GIB hires managing director for waste and bio-energy
04 October 2013The UK's rapidly expanding Green Investment Bank (GIB) has hired a new managing director for waste and bioenergy, whose remit will include helping to finance the emerging UK anaerobic digestion sector.
-
Foresight plans £200m solar IPO
05 September 2013Alternative asset manager Foresight is set to become the latest in a string of firms to launch a renewables IPO after announcing plans to raise £200 million ($311.8 million) by floating a solar fund.
-
UK strike prices to 'help renewables developers tap green bond market'
02 July 2013Proposed 'strike prices' to be paid by the UK government for renewable energy will help developers tap the green bond market, it was claimed today.